Reports indicate that there is a dissociation between markers of HIV disease progression
and clinical stage among subjects coinfected with human T-cell lymphotropic virus type I …

Objectives.—To study the effect of human T-cell lymphtropic virus type I (HTLV-I) on markers
of human immunodeficiency virus (HIV) disease progression. Design.—A retrospective …

Human T-lymphotropic virus type I (HTLV-I) and HTLV-II have been postulated to accelerate
disease progression in patients coinfected with HIV. However, recent evidence suggests that …

Human T-lymphotropic virus type II (HTLV-II) has not yet been associated with any disease.
Little is known about the proviral loads of HTLV-II in vivo and its relationship, if any, to lack of …

HTLV-I and HTLV-II infect T lymphocytes. A high HTLV-I proviral load in peripheral blood
mononuclear cells (PBMCs) has been associated with a higher risk of neurologic disease …

Several reports suggest that HTLV-I/HIV coinfection may be associated with an increased
risk of HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP). In HTLV-I …

Background. Human T cell lymphotropic virus type 2 (HTLV-2) infection is not rare among
injection drug users with human immunodeficiency virus (HIV) infection and may exert a …

To determine whether coinfection with HTLV-II influences the course of HIV-1 infection, we
evaluated the progression from asymptomatic HIV infection (CDC group II) to persistent …

Human T lymphotropic virus type I (HTLV-I) can increase human immunodeficiency virus
(HIV) replication in vitro, and several studies suggest that HTLV-I accelerates the …

Coinfections with HIV-1 and HTLV-I or HTLV-II have been associated with unique
immunophenotypes and an increased risk for development of neurodegenerative …